THE GROWING ROLE OF PERSONALIZED MEDICINE IN UROLOGY

In 2025, urology is witnessing a significant rise in precision medicine, driven by advancements in AI, machine learning, and robotic surgery.

- DR.ANIL KUMAR T

Modern healthcare depends on new innovations that customize treatment protocols through patient-specific information including genetic makeup and disease development together with therapeutic reactions. Artificial intelligence boosts diagnostics through improved precision and it shortens diagnosis times and optimizes therapeutic choices specifically in uro-oncology.

The IsoPSA tool enables doctors to verify between benign prostate cancer and clinically important cases leading to fewer superfluous biopsy procedures. The use of robotic surgery will bring better clinical results by implementing minimally invasive methods which deliver shorter recovery times coupled with reduced postoperative issues for patients. The development of these technologies shows promise to change urological operations by enhancing diagnosis speed and treatment results together with patient experience which leads to more individualized & minimally invasive treatment options

The Future of Uro-Oncology

An uro-oncologist is convinced that the future of individualized cancer treatment is precision medicine, which individualizes treatment plans according to a patient's genetic profile, tumor biology, and lifestyle. With robotic surgery providing unmatched accuracy and immunotherapy attacking cancer at the molecular level, treatments can now be made not only effective but also less toxic. The intersection of genomics, artificial intelligence, and sophisticated surgical technology is poised to improve the potential to better foretell patient outcomes and act at the best moment, actually revolutionizing uro-oncology.